U.S. Specialty Stores Stock News

Primo Brands (PRMB) has caught investor attention after recent trading, with the share price at $17.99 and mixed total returns, including about 11% over the past week and a roughly 41% decline over the past year. See our latest analysis for Primo Brands. The recent 11.1% 7-day share price return comes after a difficult period, with the 1-year total shareholder return down about 40.6% and momentum still rebuilding from that weaker longer-term performance. If Primo Brands has you reassessing...

EyePoint (EYPT) is back in focus after a recent corporate update on DURAVYU, outlining progress in Phase 3 trials for wet age related macular degeneration and diabetic macular edema, along with preparations for a potential NDA filing. See our latest analysis for EyePoint. Despite the recent DURAVYU update and funding progress, EyePoint’s share price has been volatile, with a 1 day share price return of a 5.0% decline and a 7 day share price return of a 7.2% decline. However, the 90 day share...

Freedom Capital’s new coverage of Gambling.com Group (GAMB), focused on sports data services and revised revenue guidance, has pushed the stock into the spotlight for investors tracking online gambling and data driven revenue models. See our latest analysis for Gambling.com Group. The recent initiation of coverage comes at a time when Gambling.com Group’s 90 day share price return of 31.66% decline and 1 year total shareholder return of 62.46% decline signal fading momentum, even as sports...

In the past quarter, Fastly reported stronger-than-expected results, highlighting its edge cloud and content delivery platform while still posting operating losses and facing customer churn. Beneath the headline beat, modest net revenue retention and comparatively low gross margins underscored ongoing questions about the company’s long-term profitability model. We’ll now examine how these better-than-expected results, alongside concerns over customer retention, reshape Fastly’s existing...

If you are wondering whether NIO at around US$4.64 is a bargain or a value trap, you are not alone. A closer look at how the market is pricing the stock can help frame that question. The share price has seen mixed returns, with a 9.7% decline over the last 7 days, a 7.8% decline over the last 30 days, a 9.7% decline year to date, but an 11.3% gain over the last year, while longer term holders have sat through a 60.7% three year decline and a 91.8% five year decline. These swings have kept...

In recent days, Ecolab has drawn fresh attention as William Blair analyst Tim Mulrooney reiterated a buy rating while short interest in the stock inched higher but remained well below sector averages. At the same time, Ecolab’s double ‘A’ score from CDP for water and climate leadership highlights how its sustainability profile is becoming a core part of the investment story. Next, we’ll examine how Ecolab’s renewed analyst support and CDP double ‘A’ rating may influence its existing...

Norwegian Cruise Line Holdings recently expanded its private island Great Stirrup Cay with new lagoon, adult-only, and family amenities, while a federal appeals court paused Hawaii’s planned climate tax on cruise passengers, easing a potential cost headwind for its itineraries there. At the same time, the company’s Oceania brand is sharpening its adults-only, luxury positioning and unveiling higher-end suite offerings, underscoring a broader push toward differentiated, experience-led...

What triggered the latest move in OSI Systems stock? OSI Systems (OSIS) is back in focus after its Security division secured an international order of about US$30 million to provide RF based communication and surveillance systems for multi year naval operations. See our latest analysis for OSI Systems. At a share price of US$278.92, OSI Systems has seen momentum build recently, with a 7 day share price return of 9.13% and a 1 year total shareholder return of 81.88%. This suggests investors...

Recent performance snapshot and context Reinsurance Group of America (RGA) has drawn attention after recent trading left the shares around $201.47, with a roughly 1% decline over the past week and similar softness over the month. For context, the stock shows a 5% decline over the past year. Over longer horizons, total returns are around 46% over 3 years and roughly 1x over 5 years. See our latest analysis for Reinsurance Group of America. The recent softness in RGA’s share price around...

In recent days, Watts Water Technologies has attracted attention as analysts highlighted its above-sector revenue growth, strong gross margins, and earnings expansion alongside recent acquisitions of Saudi Cast and Superior Boiler that broaden its product range and geographic footprint. This combination of solid historical financial execution and portfolio expansion has reinforced the company’s position in higher-value water management solutions, drawing renewed institutional interest. We’ll...

In early January 2026, Daiichi Sankyo Europe announced an agreement for Organon to commercialize Nilemdo® (bempedoic acid) in France, Denmark, Iceland, Sweden, Finland and Norway, targeting patients with high cholesterol and elevated cardiovascular disease risk who are not well served by statins. This commercialization deal adds a differentiated cardiovascular product to Organon’s portfolio in key European markets, expanding its role in addressing high unmet need among statin-intolerant...

If you are wondering whether Western Midstream Partners at around US$41.24 still offers value, you are not alone. This article is here to unpack that question step by step. The unit price has produced returns of 3.8% over the last week, 4.6% over the last 30 days, 3.8% year to date, 14.0% over 1 year and 91.5% over 3 years, with a very large 5 year return of 275.9% that naturally raises questions about what is already priced in. Recent attention on Western Midstream Partners has centered on...

AptarGroup (ATR) has attracted fresh attention after Ave Maria Growth Fund both initiated a position and highlighted the company as a top idea, while management recently outlined dates for its 2026 quarterly earnings conference calls. See our latest analysis for AptarGroup. AptarGroup’s recent investor attention and 2026 earnings call schedule sit against a mixed picture, with a 1-day share price return of 1.15% to US$123.85, a 90-day share price return decline of 4.89%, and a 3-year total...

BGC Group (BGC) has been drawing investor attention after recent share price pressure, with the stock down over the past month and past 3 months. This has prompted fresh interest in its valuation and business profile. See our latest analysis for BGC Group. Over the past year, BGC Group’s share price has softened, with a recent 7 day share price return of 2.80% decline and a year to date share price return of 2.80% decline. Its 3 year total shareholder return of 113.00% and 5 year total...

Tyra Biosciences recently reached a new 52-week high and expanded its leadership team with the appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer, reinforcing its focus on advancing clinical-stage biotechnology programs. An interesting aspect of this development is how the combination of fresh executive expertise and progress in two ongoing Phase 2 studies has become a focal point for how the company is being perceived. We’ll now examine...

In recent days, Sprinklr has attracted increasing investor attention for its AI-driven Unified Customer Experience Management platform, which helps enterprises manage communication across multiple channels and internal teams. This renewed interest highlights how Sprinklr’s AI capabilities are becoming more relevant for companies pursuing digital transformation and integrated customer engagement. Next, we’ll examine how Sprinklr’s growing emphasis on AI-powered customer experience tools could...

In early January 2026, several Wall Street analysts updated their views on Landstar System, with Wells Fargo upgrading the stock’s rating and others revising their assessments following a review of the company’s position in third-party logistics. These coordinated rating changes signal a shift in how the market’s research community views Landstar’s business model and industry role, which can influence how investors interpret its longer-term prospects. Next, we’ll examine how this wave of...

Donaldson Company (NYSE:DCI) has had a great run on the share market with its stock up by a significant 17% over the...

Why H.B. Fuller (FUL) is back on investor radars Fresh analysis of H.B. Fuller (FUL), highlighting a 5 year rise in return on capital employed to 8.3% and a 27% increase in capital employed, is drawing attention to the company’s reinvestment profile. See our latest analysis for H.B. Fuller. The recent focus on H.B. Fuller’s reinvestment record comes as the shares trade at $65.48, with a 90 day share price return of 12.94% and a 1 year total shareholder return of 8.57%. The 3 year total...

GATX stock at a glance after recent performance shift With no single headline event driving attention, GATX (GATX) has come into focus after a recent mix of short term pullback and longer term gains that may prompt investors to reassess the stock. See our latest analysis for GATX. At a share price of $175.88, GATX has recently seen a modest 1 day share price return decline of 1.11%. However, its 1 year total shareholder return of 19.03% and 5 year total shareholder return of 115.26% suggest...

Alnylam Pharmaceuticals recently outlined plans, now in the past, to present a company overview, early 2025 revenue figures, and a new five-year strategy at the 44th Annual J.P. Morgan Healthcare Conference, including an outlook for 2026 product sales via a live webcast. This update comes as the company is viewed as financially disciplined with net cash, strong free cash flow conversion from EBIT, and interest in its growth-at-a-reasonable-price profile. We’ll now examine how anticipation...

Zentalis Pharmaceuticals recently reported completing Part 2a enrollment in its DENALI trial, aligning with the FDA on the Phase 3 ASPENOVA design for azenosertib and outlining expectations for dose confirmation and topline data by the end of 2026. Alongside these pipeline updates, a 10 percent owner, Walters Group, bought about 6,459,973 shares for roughly US$7.70 million, underscoring insider confidence as the company also refocuses azenosertib away from uterine serous carcinoma and toward...

In early January 2026, analyst Dan Bergstrom at RBC Capital reiterated a hold rating on Commvault Systems, reflecting a cautious stance following growing interest in its data protection and cyber resilience offerings. The more cautious rating contrasts with generally upbeat analyst commentary around Commvault’s recurring revenue growth, margin trajectory, and deepening integrations with major cloud providers, underscoring how opinions differ on how much of the company’s data resilience...

In recent days, Howmet Aerospace reported strong year-over-year revenue and earnings growth across its commercial and defense aerospace segments, supported by raised financial guidance and higher shareholder returns through dividend increases and share repurchases. This performance, alongside growing demand for engine spares and robust orders tied to programs such as the F-35, has reinforced market confidence in Howmet’s role within the expanding global aerospace supply chain. With analysts...